A Study Evaluating the Safety & Efficacy of RDX013 for the Treatment of

See also
Status	Clinical Trial	Phase
Completed	`NCT03172702` - Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia	Phase 3
Terminated	`NCT05056727` - A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia	Phase 3
Recruiting	`NCT05766839` - Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age	Phase 2
Completed	`NCT02609841` - POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study	N/A
Recruiting	`NCT06277128` - A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.	Phase 2
Recruiting	`NCT04789239` - OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure	Phase 2
Completed	`NCT05029310` - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients	Phase 4
Terminated	`NCT04443608` - Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management	Phase 4
Completed	`NCT02607085` - REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study	N/A
Completed	`NCT03283267` - A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)	Phase 1
Recruiting	`NCT06036823` - 5 Versus 10 Units of Insulin in Hyperkalemia Management	Phase 4
Recruiting	`NCT05173584` - Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.	Phase 4
Completed	`NCT05184998` - Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
Completed	`NCT01737697` - Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia	Phase 3
Completed	`NCT01493024` - Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia	Phase 2
Completed	`NCT04207203` - Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study	N/A
Completed	`NCT05382988` - Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy	Phase 3
Completed	`NCT04217590` - Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects	Phase 3
Recruiting	`NCT03096561` - Measurement of Serum Potassium Rate During Accidental Hypothermia.	N/A
Completed	`NCT03326583` - The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia	Phase 2

NCT number	NCT04780841
Study type	Interventional
Source	Ardelyx
Contact
Status	Completed
Phase	Phase 2
Start date	January 11, 2021
Completion date	March 3, 2022

A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia — Redukx

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms